The HTLV receptor is an early T-cell activation marker whose expression requires de novo protein synthesis

Blood. 2003 Mar 1;101(5):1913-8. doi: 10.1182/blood-2002-09-2681. Epub 2002 Oct 17.

Abstract

The human T-cell leukemia virus type 1 (HTLV) is the first isolated human retrovirus, but its receptor has yet to be identified, in part due to its ubiquitous expression. Here we report that quiescent CD4 and CD8 T lymphocytes do not express this receptor, as monitored with a soluble receptor-binding domain derived from the HTLV envelope. However, HTLV receptor is an early activation marker in neonatal and adult T lymphocytes, detected as early as 4 hours following T-cell-receptor (TCR) stimulation. This induced surface expression of the HTLV receptor requires de novo protein synthesis and results in a wide distribution on the surface of activated lymphocytes. Moreover, the distribution of the HTLV receptor is independent of TCR/CD3-capped membrane structures, as observed by confocal immunofluorescence microscopy. To determine whether HTLV receptor up-regulation specifically requires TCR-mediated signals or, alternatively, is dependent on more generalized cell cycle entry/proliferation signals, its expression was monitored in interleukin 7 (IL-7)-stimulated neonatal and adult T cells. Neonatal, but not adult, lymphocytes proliferate in response to IL-7 and HTLV receptor expression is restricted to the former population. Thus, HTLV receptor expression appears to be an early marker of cell cycle entry. Up-regulation of the HTLV receptor, via signals transmitted through the IL-7 cytokine receptor as well as the TCR, is likely to contribute to the mother-to-infant transmission and spreading of HTLV-1.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers
  • Cell Cycle
  • Female
  • Gene Expression Regulation / drug effects
  • Gene Products, env / metabolism
  • Genes, env
  • HTLV-I Infections / transmission*
  • Humans
  • Infant, Newborn
  • Infectious Disease Transmission, Vertical
  • Interleukin-7 / pharmacology
  • Leukemia Virus, Murine / genetics
  • Lymphocyte Activation* / drug effects
  • Maternal-Fetal Exchange
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Pregnancy
  • Receptor-CD3 Complex, Antigen, T-Cell / immunology
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Interleukin-7 / physiology
  • Receptors, Virus / biosynthesis*
  • Receptors, Virus / genetics
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction
  • T-Lymphocyte Subsets / drug effects
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism*

Substances

  • Biomarkers
  • Gene Products, env
  • HTLV-I receptor
  • Interleukin-7
  • Receptor-CD3 Complex, Antigen, T-Cell
  • Receptors, Antigen, T-Cell
  • Receptors, Interleukin-7
  • Receptors, Virus
  • Recombinant Fusion Proteins